Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01658007
Title Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

lymphoblastic lymphoma

acute lymphoblastic leukemia

Therapies

Sirolimus

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.